Novel ophthalmic therapeutic modalities based on noninvasive light-targeted drug delivery to the posterior pole of the eye

Advanced Drug Delivery Reviews

Volumn 52, Issue 1, 2001, Pages 49-61

  Zeimer, R ^a   Goldberg, M F ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Age related macular degeneration; Choroidal neovascularization; Drug delivery; Eye; Laser; Liposomes; Photodynamic

Indexed keywords

DIPALMITOYLPHOSPHATIDYLCHOLINE; DIPALMITOYLPHOSPHATIDYLGLYCEROL; LIPOSOME; MACROGOL;

ARTICLE; BLOOD VESSEL OCCLUSION; CHOROID VASCULARIZATION; DRUG DELIVERY SYSTEM; FLUORESCENCE ANGIOGRAPHY; LASER; LIGHT; NONHUMAN; PHOTODYNAMIC THERAPY; POSTERIOR EYE CHAMBER; PRIORITY JOURNAL; RETINA BLOOD FLOW; RETINA BLOOD VESSEL; SUBRETINAL NEOVASCULARIZATION; TECHNIQUE; TEMPERATURE;

EID: 0035980340     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(01)00194-6     Document Type: Review

References (35)

1. A potential method for local drug and dye delivery in the ocular vasculature
2. Feasibility of blood flow measurement by externally controlled dye delivery
3. Quantitative analysis of retinal hemodynamics using targeted dye delivery
4. Liposomes containing synthetic lipid derivatives of poly (ethylene glycol) show prolonged circulation half-lives in vivo
5. Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potential
6. Age-related macular degeneration and blindness due to neovascular maculopathy
7. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: One-year results of 2 randomized clinical trails-tap report 1
8. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: Results of retreatments in a phase 1 and 2 study
9. Noninvasive visualization of the choriocapillaris and its dynamic filling
10. Feasibility of laser-targeted photoocclusion of the choriocapillary layer in rats
11. Laser targeted photodynamic therapy occludes experimental choroidal neovascularization without visible damage to RPE and choriocapillaris
12. Comparison between blood flow in experimental choroidal neovascularization and in normal choriocapillaris
13. Selective visualization of choroidal neovascular membranes
14. Effects on the RPE following choriocapillaris occlusion induced by laser targeted photo-occlusion and conventional photodynamic therapy
15. Electron microscopic assessment of the effect of laser targeted photodynamic therapy on choroidal neovascularization and adjacent RPE and choriocapillaris
16. Feasibility of targeted drug delivery to selective areas of the retina
17. Noninvasive visualization of the blood flow in the choriocapillaris of the normal rat
18. Visualization of the retinal microvasculature by targeted dye delivery
19. Laser-triggered repetitive fluorescein angiography
20. Age-related macular degeneration
21. Subfoveal neovascular lesions in age-related macular degeneration: Guidelines for evaluation and treatment in the macular photocoagulation study
22. Indocyanine green videoangiography of choroidal neovasculariztion
23. Determination of retinal blood velocity with respect to the cardiac cycle using laser-triggered release of liposome-encapsulated dye
24. Local response of the primate retinal microcirulation to increased metabolic deman induced by flicker
25. Studies of the retinal circulation in man: Observations on vessel diameter, arteriovenous oxygen difference, and mean circulation time
26. Liposomes opportunities in drug delivery
27. Toxicity of non-drug-containing liposomes for cultured human cells
28. Systemic administration of doxorubicin-containing liposomes in cancer patients: A phase I study
29. Phase I clinical and pharmacological study of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II)
30. Phase I trial of the ImmTher, a new liposome-incorporated lipophilic disaccharide tripeptide
31. A phase I clinical trail and pharmacokinetic evaluation of liposome-encapsulated doxorubicin
32. Systemic toxicology and laser safety of laser targeted angiography with heat sensitive liposomes